Apollomics Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 5 purchases
- Chen Yi-KueiChief Operating Officer · Aug 14, 2026Bought 20,000 sharesabout $300 thousand ·
- LIN PETER KUAN-HOWChief Financial Officer · Aug 14, 2026Bought 26,667 sharesabout $400 thousand ·
- Chen Hung-WenChief Executive Officer · Aug 14, 2026Bought 166,667 sharesabout $2.0 million ·
- Chen Hung-WenChief Executive Officer · Aug 14, 2026Bought 103,333 sharesabout $1.5 million ·
- Chen Hung-WenChief Executive Officer · Aug 14, 2026Bought 266,667 sharesabout $4.0 million ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- None in the last 12 months.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.